Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép
Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu